Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép
Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu